Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép
Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu